Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép
Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu